Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép
Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu